Medical conditions

Pharmacists encouraged to report GLP-1 side effects amid pharmacogenomics study

The Medicines and Healthcare products Regulatory Agency has called on healthcare professionals to submit Yellow Card reports on behalf of patients who develop acute pancreatitis while using GLP-1 receptor agonists.…

Pharmacy bodies warn that demand for weight-loss drug will outstrip supply

Around 220,000 patients could be prescribed Mounjaro in the first three years of the drug's availability to NHS patients in England, the National Institute for Health and Care Excellence has estimated.…

RPS asked for clarification on dispensing timelines following death of patient with diabetes

A coroner has issued a ‘Prevention of future deaths’ report seeking information on a repeat prescribing toolkit published by the Royal Pharmaceutical Society and Royal College of GPs.…

Pharmacy First uptake ‘not what we would like it to be’, says minister

Pharmacy minister Stephen Kinnock said that the government will work to reform the financial arrangements for Pharmacy First to incentivise pharmacists to embrace the scheme.…

Test your knowledge of neurodevelopment and neurological conditions

From ADHD and autism, to multiple sclerosis and seizure disorders, neurological conditions affect a huge proportion of the UK population. Here, test your knowledge of these common and often complex conditions.…

People with sickle cell disease face racism and ‘sub-standard care’, finds report

A report commissioned by the NHS Race and Health Observatory recommends that more sickle cell training for healthcare professionals, including primary care, is needed.…

NICE rejects Alzheimer’s disease drugs for third time

The National Institute for Health and Clinical Excellence said the benefits of donanemab and lecanemab in the treatment of Alzheimer's disease are too small to justify their high costs to the NHS.…

Community pharmacies in 2024/2025 administered highest number of flu vaccinations outside of pandemic

Of the 4 million flu vaccinations delivered by community pharmacies in England during the 2024/2025 flu season, data show that 11% were administered in the most deprived areas.…

Case-based learning: understanding and managing levetiracetam-induced psychiatric symptoms

This article highlights the psychiatric adverse effects of levetiracetam, emphasising the importance of recognising these effects rather than attributing them to an organic diagnosis.…

NICE recommends ‘breakthrough’ therapy for blood cancer

Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…